Occupe actuellement des postes chez Astex Pharmaceuticals Inc and Xenon Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chief Medical Officer | Astex Pharmaceuticals Inc | 21 juillet 2009 - |
Independent Director | Xenon Pharmaceuticals Inc | 1 octobre 2003 - |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2022-05-25 | 2022-05-24 |
DURECT Corp
(DRRX)
|
A Achat |
5 000
+9.1%
0,391 950 USD |
5 000 +9.1% | 0,39 | 1 950 USD | |
2022-05-25 | 2022-05-24 |
DURECT Corp
(DRRX)
|
A Achat |
10 000
+22.2%
0,393 889 USD |
10 000 +22.2% | 0,39 | 3 889 USD | |
2022-05-25 | 2022-05-24 |
DURECT Corp
(DRRX)
|
A Achat |
5 000
+12.5%
0,381 895 USD |
5 000 +12.5% | 0,38 | 1 895 USD | |
2022-05-25 | 2022-05-24 |
DURECT Corp
(DRRX)
|
A Achat |
5 000
+14.3%
0,391 942 USD |
5 000 +14.3% | 0,39 | 1 942 USD | |
2022-05-25 | 2022-05-24 |
DURECT Corp
(DRRX)
|
A Achat |
5 000
+16.7%
0,391 963 USD |
5 000 +16.7% | 0,39 | 1 963 USD | |
2022-05-18 | 2022-05-17 |
DURECT Corp
(DRRX)
|
A Achat |
1 800
+6.4%
0,42758 USD |
1 800 +6.4% | 0,42 | 758 USD | |
2022-05-18 | 2022-05-17 |
DURECT Corp
(DRRX)
|
A Achat |
8 900
+46.1%
0,423 749 USD |
8 900 +46.1% | 0,42 | 3 749 USD | |
2022-05-18 | 2022-05-17 |
DURECT Corp
(DRRX)
|
A Achat |
9 300
+93.0%
0,423 899 USD |
9 300 +93.0% | 0,42 | 3 899 USD | |
2022-05-18 | 2022-05-16 |
DURECT Corp
(DRRX)
|
A Achat |
10 000
+inf%
0,383 767 USD |
10 000 +inf% | 0,38 | 3 767 USD | |
2019-09-17 | 2019-09-13 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
23
-0.0%
9,31214 USD |
23 -0.0% | 9,31 | 214 USD |